載入...
Immuno-Oncotherapeutic Approaches in Advanced Hepatocellular Carcinoma
Advanced hepatocellular carcinoma has limited treatment options, but there has been extensive growth recently with cabozantinib, regorafenib, lenvatinib, nivolumab, atezolizumab, and bevacizumab, which are some of the treatments that have received FDA approval just over the last three years. Because...
Na minha lista:
| Main Authors: | , , , , |
|---|---|
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
MDPI AG
2020-08-01
|
| 叢編: | Vaccines |
| 主題: | |
| 在線閱讀: | https://www.mdpi.com/2076-393X/8/3/447 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|